The global infection control market has the potential to grow by USD 29.49 billion during 2020-2024, and the market’s growth momentum will accelerate throughout the forecast period.
This report provides a detailed analysis of the market by geography (Asia, Europe, North America, and ROW) and type (therapeutic and non-therapeutic). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including 3M Co., Astellas Pharma Inc., Cantel Medical Corp., Ecolab Inc., Getinge AB, GlaxoSmithKline Plc, Merck & Co. Inc., Mylan NV, Pfizer Inc., and Sanofi.
Market Overview
Browse TOC and LoE with selected illustrations and example pages from infection control market report
Market Competitive Analysis
The market is moderately fragmented, and the degree of fragmentation will increase during the forecast period. The players in the market are diversified and industry-specific in terms of their overall offerings. Established vendors are focusing on investing in R&D activities and integrating technological advances into their products to cater to a variety of customer segments. Mylan NV, Pfizer Inc., and Sanofi are a few of the major market participants. Although the accelerating growth momentum will offer immense growth opportunities, the concerns regarding the safety of reprocessed instruments will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
To help clients improve their market positions, this infection control market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market’s competitive landscape and offers information on the products offered by various companies. Moreover, this infection control market analysis report also provides information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.
This report provides information on the production, sustainability, and prospects of several leading infection control companies, including:
- 3M Co.
- Astellas Pharma, Inc.
- Cantel Medical Corp.
- Ecolab Inc.
- Getinge AB
- GlaxoSmithKline Plc
- Merck & Co., Inc.
- Mylan NV
- Pfizer Inc.
- Sanofi.
Infection Control Market: Segmentation by Region
For more insights on the market share of various regions Request for a FREE sample now!
North America was the largest market for infection control in 2019, and the region will continue to offer growth opportunities to market vendors during the forecast period. Pharmaceutical companies have increased investments in R&D activities for the production of improved drugs and also to adhere to stringent regulations for drug approval. These factors are contributing to the infection control market share growth.
Almost 33% of the market’s growth will originate from North America during the forecast period. The rising incidence of infectious diseases is increasing the demand for infection control interventions, creating significant business opportunities for many market vendors in the region. The US, Canada, and Mexico are the key markets for infection control in North America. Market growth in the region will be faster than the growth of the market in Asia and ROW.
Infection Control Market: Segmentation by Type
Request for a FREE sample and Get more information on the market contribution of various types
The players in the therapeutics market segment offer anti-infectives, such as antibiotics, anti-fungal drugs, and anti-viral drugs, which are used for the prevention and treatment of various infectious diseases. Moreover, expenditure on infection control therapeutic regimen is also increasing owing to the rising prevalence of infections.
Moreover, market growth by the therapeutic segment will be faster than the growth of the market by the non-therapeutic segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the infection control market size.
Infection Control Market: Key Drivers and Trends
The geriatric population is the most important sub-group that is majorly prone to contracting periodontal diseases compared with the adult population. Infectious diseases are the common cause of morbidity and mortality in geriatric patients. Infections such as pneumonia, urinary tract infection, and bacterial spectrum are often accompanied by the presence of serious complications in this sub-group. Therefore, the growing proportion of the geriatric population is increasing the need for immediate treatment with infection control therapeutics is increasing. For instance, in the US, the geriatric population is increasing at a rapid rate. These factors are contributing to the infection control market growth.
- Technological advances in sterilization equipment is one of the significant global infection control market trends.
- Vendors are increasingly exhibiting interest in developing effective measures as infection control solutions.
- Vendors are developing novel measures such as the use of UV rays to reduce the prevalence of nosocomial infections.
- This, in turn, will reduce incidences of HAIs, reducing the health burden and economic costs associated with them.
- The above factors are contributing to the market growth.
- Another significant trend contributing to market growth is the provision of healthcare services to individuals by public and private organizations.
- During 2020-2024, the market will grow at a CAGR of over 4%.
Request for a FREE sample now!
Infection Control Market: Key Highlights of the Report for the Forecast Period 2020-2024
- CAGR of the market during the forecast period 2020-2024
- Detailed information on factors that will accelerate the infection control market growth during the next five years
- Precise estimation of the global infection control market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the infection control industry across Asia, Europe, North America, and ROW
- A thorough analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of infection control vendors
We can help! Our analysts can customize this report to meet your requirements. Get in touch